methylation

May 9, 2022

Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism
Premium

Apr 13, 2022

Guardant Health, Exact Sciences Make Progress on Multi-Cancer Detection Tests
Premium

Mar 31, 2022

New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch
Premium

Feb 3, 2022

Australian Researchers Adapt Melt Curve Methylation Test for Infant Rare Genetic Disorder Screening
Premium

Feb 2, 2022

Cell-Free DNA Assay Shows Promise for Detecting Stem Cell Transplant Complications
Premium

Jan 7, 2022

Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom
Premium

Jan 5, 2022

Nucleix Raises Additional $22M

Sep 23, 2021

Zymo Research Gets CE Mark for DNA Methylation Kit

Jul 1, 2021

Canadian Liquid Biopsy Startup Adela to Pursue Cancer Early Detection Tests
Premium

Jun 23, 2021

Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round

Jun 15, 2021

South Korean Firm EDGC to Expand Reach Into Liquid Biopsy Space With Cell-Free DNA Platform
Premium

Jun 11, 2021

Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership

Jun 3, 2021

Nucleix, MD Anderson Partner on Methylation-Based Lung Cancer Dx Tests

May 26, 2021

Burning Rock Embarks on Large-Scale Study for 22-Cancer Screening Assay
Premium

May 19, 2021

BGI Genomics Nabs CE Mark for Colorectal Cancer Screening Test

May 18, 2021

TruDiagnostic Receives CLIA Certification for Kentucky Laboratory

Apr 15, 2021

Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches
Premium

Apr 1, 2021

Guardant Health Receives New York State Approval for Guardant Reveal MRD Test

Mar 11, 2021

Burning Rock Q4 Revenues Rise 50 Percent

Feb 26, 2021

Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch
Premium